Gene · 10112
Papers1,613
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,613
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ionizing radiation induces senescence of dermal papilla cells through inhibiting the FOXM1-KIF20A pathway. | Genes Dis | 2027 | 42733528 | PubTator, text mining | PubMed |
| Identification of functional genes and immune cell infiltration analysis in liposarcoma. | PLoS One | 2026 | 42726806 | PubTator, text mining | PubMed |
| Microplastics and nanoplastics-related genes signature predicts prognosis in pancreatic ductal adenocarcinoma and functional validation of interleukin 1 alpha. | Transl Cancer Res | 2026 | 42724844 | PubTator, text mining | PubMed |
| Identification of a cholesterol metabolism-related signature based on KIF20A and NDC80 for prognostic stratification and immunotherapy prediction in hepatocellular carcinoma. | Cancer Biomark | 2026 | 42685023 | PubTator, text mining | PubMed |
| MicroRNA Signatures of Fulvestrant-Treated Luminal Breast Cancer Cells: Identification of Therapeutic Targets Regulated by miR-374b-5p. | Int J Mol Sci | 2026 | 42589442 | PubTator, text mining | PubMed |
| Kinesins in Bladder Cancer: Integrating Molecular Mechanisms and Treatment Approaches. | Cell Biol Int | 2026 | 42529891 | PubTator, text mining | PubMed |
| Unveiling immune-related gene signatures in triple negative breast cancer through integrated transcriptomic analysis. | Biomedicine (Taipei) | 2026 | 42483440 | PubTator, text mining | PubMed |
| Targeting mitotic kinesin KIF20A: A differentiation-based therapeutic strategy for glioblastoma stem/progenitor cells. | Stem Cell Reports | 2026 | 42462712 | PubTator, text mining | PubMed |
| KIAA1429 promotes gallbladder cancer progression through m6A-dependent post-transcriptional modification of KIF20A. | Sci Rep | 2026 | 42437826 | PubTator, text mining | PubMed |
| Large-scale transcriptome analysis reveals KIF20A as a novel indicator of cisplatin resistance in high-grade serous ovarian cancer. | J Ovarian Res | 2026 | 42426841 | PubTator, text mining | PubMed |
| Integrative Transcriptomic Analysis Identifies Hypoxia-responsive Cell Cycle Hub Genes as Prognostic Markers in Glioblastoma. | Ann Neurosci | 2026 | 42405025 | PubTator, text mining | PubMed |
| KIF20A in Human Malignancies: Oncogenic Mechanisms and Therapeutic Targeting Strategies. | Mini Rev Med Chem | 2026 | 42381127 | PubTator, text mining | PubMed |
| Common and Unique Respiratory Health Risk Induced by Urban-Rural PM2.5 in the Chengdu-Chongqing Economic Circle. | Toxics | 2026 | 42347429 | PubTator, text mining | PubMed |
| Polyamine-related 4-gene prognostic signature in hepatocellular carcinoma. | Medicine (Baltimore) | 2026 | 42332538 | PubTator, text mining | PubMed |
| X-ray irradiation suppresses keloid growth by inducing G2/M arrest through the phytosphingosine-KIF20A axis. | J Invest Dermatol | 2026 | 42309385 | PubTator, text mining | PubMed |
| WTAP tetramer ensures m6A writer assembly and faithful mitosis. | EMBO Rep | 2026 | 42231024 | PubTator, text mining | PubMed |
| Kinesin KIF20A Regulated by ATF2 Transcription Promotes Prostate Cancer Proliferation and Invasion. | Front Biosci (Landmark Ed) | 2026 | 42216528 | PubTator, text mining | PubMed |
| Integrated transcriptomic analysis reveals a lncRNA-miRNA-TF-mRNA regulatory network underlying quercetin's anti-hepatocellular carcinoma effects. | Biochem Biophys Res Commun | 2026 | 41962406 | PubTator, text mining | PubMed |
| Glioma biomarker analysis and drug targeting prediction based on ferroptosis-related genes. | Medicine (Baltimore) | 2026 | 41961695 | PubTator, text mining | PubMed |
| Targeting KIF20A blocks lactylation modification to suppress immune escape in hepatocellular carcinoma. | iScience | 2026 | 41952973 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10112/papers